NCT00646607 FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer Status COMPLETED Phase PHASE3
NCT00630786 Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study Status COMPLETED Phase PHASE1/PHASE2
NCT00625651 Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00622999 Effects of Malnutrition on Colon Cancer Patients With Abdominal Surgery Status COMPLETED Phase N/A
NCT00622557 General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) Status COMPLETED Phase N/A
NCT00600496 A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) Status COMPLETED Phase PHASE1
NCT00587964 Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases Status COMPLETED Phase PHASE2
NCT00582621 Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders Status RECRUITING Phase N/A
NCT00579514 Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT00578396 Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention Status WITHDRAWN Phase PHASE1
NCT00574678 Analyzing the Composition of Tears to Identify Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00572143 Follow-up After Surgery for Colon Cancer. General Practice vs. Surgical-based Follow-up? Status COMPLETED Phase NA
NCT00534053 Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial Status COMPLETED Phase NA
NCT00533975 A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy Status UNKNOWN Phase N/A
NCT00532987 Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer Status TERMINATED Phase N/A